Cargando…
Role of Allogeneic Transplantation in Multiple Myeloma in the Era of New Drugs
High-dose melphalan with autologous stem cell rescue has been regarded as the standard of care for patients with newly diagnosed myeloma up to the age of 65–70 years. The recent development of agents with potent anti-tumor activity such as thalidomide, lenalidomide and bortezomib has further improve...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Università Cattolica del Sacro Cuore
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033139/ https://www.ncbi.nlm.nih.gov/pubmed/21415966 http://dx.doi.org/10.4084/MJHID.2010.013 |